Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications

Table 2 Summary of patients with concomitant cholangiocarcinoma

Case	Age/sex	Stone location	Procedure	Residual/recurrent stones	Margin	pTNM	Interval from CCA to death (mo)
89	50/F	R	S5/6/7	-/-	Free	T1 N1 M0	3
90	68/F	L	LH	-/-	Free	T1 Nx M0	Alive (140)
119	82/F	L	LL	-/-	Atypical mucinous epithelium	T1 Nx M0	73
128	60/M	L	LH	-/-	Free	T1 N0 M0	3 (hypopharyngeal tumor)
142	39/F	L	LL	-/-	Free	T4 N1 M0	3
212	76/F	L	S2	-/-	Inadequate	T1 Nx M0	56
227	61/F	L	LH + RA	-/+	Free	T1 N0 M0	107 (re-operated 4 years later due to CCA recurrence at CBD)
253	72/F	L	LH	-/-	Free	T1 N0 M0	Alive (49)
143	50/F	BI	LH + S5	-/+	Free	T1 Nx M0	Alive (119) (re-operated 5 years later due to CCA recurrence at CBD)
217	56/F	BI	RH	+/-	Inadequate	T2a Nx M0	5

L: Left; R: Right; BI: Bilateral; LH: Left hemihepatectomy; LL: Left lateral sectionectomy; RH: Right hemihepatectomy; RA: Right anterior sectionectomy; S5: Segment 5; S2: Segment 2; CCA: Cholangiocarcinoma; CBD: Common bile duct; pTNM: Pathologic TNM stage for intrahepatic bile duct according to AJCC 7th edition; F: Female; M: Male.